Trial intelligence / Profile preview

Phase III trial of weekly induction chemotherapy before chemoradiation vs chemoradiation alone in locally advanced cervical cancer

2011-001300-35Phase 3Unknown

Sponsor: University College London
Start: Nov 2011
Modality: DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries: 1

Overview

Phase 3, randomised trial of carboplatin and paclitaxel in Cervical Cancer (CC) (2 arms), sponsored by University College London. Primary endpoint: overall survival. Status: unknown.

Drugs

carboplatinpaclitaxel

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on 2011-001300-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001300-35.